These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28705587)

  • 1. Diagnosis of Parkinson's disease and the level of oxidized DJ-1 protein.
    Yamagishi Y; Saigoh K; Saito Y; Ogawa I; Mitsui Y; Hamada Y; Samukawa M; Suzuki H; Kuwahara M; Hirano M; Noguchi N; Kusunoki S
    Neurosci Res; 2018 Mar; 128():58-62. PubMed ID: 28705587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for Parkinson's disease].
    Ogawa I; Saito Y; Saigoh K; Hosoi Y; Mitsui Y; Noguchi N; Kusunoki S
    Brain Nerve; 2014 Apr; 66(4):471-7. PubMed ID: 24748095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DJ-1 as a Biomarker of Parkinson's Disease.
    Saito Y
    Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
    Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson's disease patients.
    Saito Y; Akazawa-Ogawa Y; Matsumura A; Saigoh K; Itoh S; Sutou K; Kobayashi M; Mita Y; Shichiri M; Hisahara S; Hara Y; Fujimura H; Takamatsu H; Hagihara Y; Yoshida Y; Hamakubo T; Kusunoki S; Shimohama S; Noguchi N
    Sci Rep; 2016 Jul; 6():30793. PubMed ID: 27470541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.
    Herbert MK; Eeftens JM; Aerts MB; Esselink RA; Bloem BR; Kuiperij HB; Verbeek MM
    Parkinsonism Relat Disord; 2014 Jan; 20(1):112-5. PubMed ID: 24075122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.
    Watanabe Y; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Uchiyama T; Kadowaki T; Matsubara T; Hirata K
    Intern Med; 2017 Nov; 56(21):2871-2878. PubMed ID: 28943542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients.
    Saito Y; Hamakubo T; Yoshida Y; Ogawa Y; Hara Y; Fujimura H; Imai Y; Iwanari H; Mochizuki Y; Shichiri M; Nishio K; Kinumi T; Noguchi N; Kodama T; Niki E
    Neurosci Lett; 2009 Nov; 465(1):1-5. PubMed ID: 19733211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
    Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
    Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy.
    Murakami N; Sako W; Haji S; Furukawa T; Otomi Y; Otsuka H; Izumi Y; Harada M; Kaji R
    J Neurol Sci; 2020 Feb; 409():116627. PubMed ID: 31865188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    Mov Disord; 2014 Nov; 29(13):1599-605. PubMed ID: 25258345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of blink reflex in multisystem atrophy, progressive supranuclear palsy and Parkinson disease.
    Szmidt-Salkowska E; Gawel M; Jamrozik Z; Salkowska-Wanat J; Gawel D; Kaminska A
    Neurol Neurochir Pol; 2016; 50(5):336-41. PubMed ID: 27591058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases.
    Ohmichi T; Mitsuhashi M; Tatebe H; Kasai T; Ali El-Agnaf OM; Tokuda T
    Parkinsonism Relat Disord; 2019 Apr; 61():82-87. PubMed ID: 30502924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Bukhatwa S; Zeng BY; Rose S; Jenner P
    Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.